What is Altimmune's interest income?

Altimmune (ALT) reported interest income of $2.9M in Q1 2026.

How has Altimmune's interest income changed year-over-year?

Altimmune's interest income increased by 87.8% year-over-year, from $1.55M to $2.9M.

What is the long-term trend for Altimmune's interest income?

Over 4 years (2021 to 2025), Altimmune's interest income has grown at a 146.9% compound annual growth rate (CAGR), from $203K to $7.54M.

What does interest income mean?

Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Altimmune ALT Interest Income

Interest Income at other companies

Madrigal Pharmaceuticals, Inc.MDGL

$8.24M-12.0%

Wave Life SciencesWVE

$5.29M+84.0%

MeiraGTx Holdings plcMGTX

$189K-80.5%

Mirum Pharmaceuticals, Inc.MIRM

$3.4M+12.5%

BioCryst PharmaceuticalsBCRX

$2.26M-25.4%

Travere Therapeutics, Inc.TVTX

$2.58M-31.9%

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's interest income?: Altimmune (ALT) reported interest income of $2.9M in Q1 2026.
How has Altimmune's interest income changed year-over-year?: Altimmune's interest income increased by 87.8% year-over-year, from $1.55M to $2.9M.
What is the long-term trend for Altimmune's interest income?: Over 4 years (2021 to 2025), Altimmune's interest income has grown at a 146.9% compound annual growth rate (CAGR), from $203K to $7.54M.
What does interest income mean?: Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.